Thanks Patientlywaiting. The naked shorting article link describes the trading pattern, message board communication and "anonymous author article analyst" dynamics experienced by TCLN/PPHM perfectly, but for the exception of PPHM being chided by Judge Laster of the Delaware Court after his determination that the current BOD significantly overcompensated themselves compared to the norm for other biotech companies.
One secondary link suggests that higher trading volume combined with greater than 50% naked shorting is a red flag that the stock is being targeted by hedge fund short interests who are using naked shorting to drive down the pps. So "Duh", PPHM has been posting daily naked shorting percentages above 50% for many weeks and has frequent excursions to greater than 70% daily naked shorting, smothering the period before and after the reverse split and announced management takeover attempt.
Avid revenue, which has been the underlying positive under development over the last decade for hope it will grow enough to enable PPHM to become a self funding research company, has been converted to a negative by becoming the focus for turning PPHM the research company into PPHM/Avid the CDMO that needs to halt research in order to enable responsible fiscal management. The fall back mechanism has now become the only means cited for some shareholder valuation delivery to long retail investors.
Interesting times.
Best wishes and "In my uninformed and troubled opinion".
KT
News 
Market Data 
Discover 
AI
